Ace Daily News

(MELBOURNE) PM Press Conference Statement Report: Scott Morrison, Paul Kelly, Brendan Murphy & Greg Hunt on preferred vaccine Pfizer for adults under 50yr-of-age #AceHealthDesk report

#AceHealthReport – Apr.11: During an evening press conference, Prime Minister Scott Morrison was joined by Chief Health Officer Paul Kelly, Department of Health Secretary Professor Brendan Murphy and Health Minister Greg Hunt:

#CoronavirusNewsDesk – Pfizer is the preferred vaccine for Australians under 50. Here are the key quotes from the PM’s update: The Australian government has announced Pfizer as the preferred vaccine for adults under the age of 50 amid concerns of rare blood clots potentially linked to the AstraZeneca vaccination.

3m 53s

Play Video. Duration: 1 minute 26 seconds
Prime Minister Scott Morrison said the government accepted the recommendations from ATAGI to prioritise Pfizer in adults under the age of 50.

There’s been some big developments in Australia’s COVID-19 vaccination rollout.

Here are the key quotes summarising the unexpected COVID-19 update.

Prime Minister Scott Morrison:

“We’ve had our successes over the course of the last year, but we’ve also had our setbacks, and we’ve indeed had our heartbreaks as well. Tonight, we have received advice from ATAGI (Australian Technical Advisory Group on Immunisation) in the last 15 minutes, and we thought it was important that we came and briefed you on that this evening so it was available immediately to Australians.”

A vaccine packet on a shelf
The European Union’s medical regulator found blood clots were a rare occurrence in young adult recipients of the AstraZeneca vaccine. (AAP)

Chief Health Officer Paul Kelly:

“The ATAGI recommendations are the following: At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccinein adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccine.”

“This is based both on the increased risk of complications from COVID-19 with increasing age, and thus increased benefit of the vaccination, and the potentially lower, but not zero risk, of this rare event with increasing age.”

“The second recommendation is that immunisation providers should only give a first dose of AstraZeneca COVID-19 vaccine to adults under 50 years of age where benefit clearly outweighs the risk for that individual’s circumstances.”

A patient is injected with a vaccine during a clinical trial.
One Australian was hospitalised after developing blood clots after being vaccinated.(AP)

“The third recommendation is people that have had their first dose of the COVID-19 AstraZeneca without any serious adverse events can safely be given their second dose.”

“Just to reiterate: this is a very rare event. At the moment, it seems to be around 4 to 6 per million doses of vaccine. It’s only been found in the first dose of the AstraZeneca vaccine, usually within four to 10 days after that vaccine. But it is serious, and it can cause up to a 25 per cent death rate when it occurs.”

“The final recommendation is that the Department of Health further develop and refine resources for informed consent that clearly convey the benefits and the risks of the AstraZeneca vaccine for both immunisation providers and consumers of all ages, and that is underway, that work, and that will be provided overnight and into the morning.”

Play Video. Duration: 3 minutes 53 seconds
Casey Briggs looks at Australia’s progress with the COVID-19 vaccine rollout

Department of Health Secretary Professor Brendan Murphy:

All vaccines have adverse effects. Some serious. Flu vaccines do. The Pfizer vaccine has a risk of anaphylaxis, which we’ve seen. But this syndrome, after all of the work we’ve done with the UK and Europe, does seem to be a real syndrome, and we now feel that, at an abundance of caution, given that this syndrome seems to occur mainly in younger people for whom the risk of severe COVID is not so great, that there is a basis to have a preferred recommendation for those under 50.

“I want to reiterate that we are strongly encouraging those 50 and over to take up the AstraZeneca vaccine. It is a highly effective vaccine at preventing severe COVID. The risk is extraordinarily low. I’ve had my first dose. I’ll have my second dose.”

Play Video. Duration: 2 minutes 25 seconds
Professor Brendan Murphy explains the changes to Australia’s vaccine rollout.

Health Minister Greg Hunt:

“We have a strong, clear vaccine program that will have passed 1 million people during the course of today, and will continue particularly in that over-50 group, which will be unaffected.”

Prime Minister Scott Morrison:

“The key principle of our management of the COVID-19 pandemic has been always to base our decisions on the expert medical advice. It has not been our practice to jump at shadows. It has not been our practice to take unnecessary precautions. We’ve been taking the necessary precautions based on the best possible medical advice. We have always taken the time to ensure we get that advice, consider it carefully, and make decisions in the best interests of Australians. And those best interests, principally, have to address the health of Australians.”

“There are, of course, Pfizer vaccines that are in Australia, and we are getting a regular supply of those, and they can be prioritised against the individuals for whom that will be the more appropriate vaccine for them. But we will just have to work through the logistics of thatand the calibration of how that is done, and that will be our task now.

#AceHealthDesk report ………Published: Apr.11: 2021:

Editor says #AceNewsDesk reports by and all our posts, also links can be found at here for Twitter and Live Feeds and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com